Key result
Review details central noradrenergic pathways in anxiety spectrum disorders and outlines emerging treatment targets.
Why the study?
Abnormalities in the noradrenergic system have been identified in anxiety disorders such as panic disorder, but current conceptualizations of pathophysiologies require elucidation.
Population
Patients with anxiety spectrum disorders including panic disorder, generalized anxiety disorder, and phobias
Design
Review article
Authors
Loading...
Synthesizes noradrenergic pathways in anxiety; leaves open targeted trials in cardiovascular patients with comorbid anxiety.
This review summarizes the role of the noradrenergic system in the pathophysiology and treatment of anxiety spectrum disorders.
Sullivan et al. (1999) conducted a review in Anxiety spectrum disorders (panic disorder, generalized anxiety disorder, phobias). Noradrenergic system was evaluated. This review delineates the central functions of the noradrenergic system in anxiety spectrum disorders, discussing relevant neuroanatomic pathways and implications for treatment.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: